Please assess the completion status of the following clinical trial:

Trial Title: Influence of Blue Light Filtering Intraocular Lenses on Daytime Levels of Melatonin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~Patients are included if they meet all of the following inclusion criteria:~* Cataract on one or both eyes~* Study eye with non-exudative AMD AREDS I - III~* Men or women aged between 60 - 99 years~* Patient planned for cataract surgery and in need of an intraocular lens~Exclusion Criteria:~Patients are excluded if they meet one or more of the following exclusion criteria:~* Study eye with exudative AMD~* Study eye with concomitant retinal or choroidal disorder other than AMD~* Study eye with significant keratopathies~* Fundus not visible~* Intake of medication known to affect melatonin secretion (within the last 12 hours): ß-blockers, calcium channel blockers, a-blockers, non-steroidal anti-inflammatory drugs, benzodiazepines, antidepressants, hypnotic drugs, antipsychotics, barbiturates, antiepileptic drugs, and melatonin~* Alcohol or caffeine consumption 6 hours before vein puncture~* Patients who are unwilling to adhere to visit examination schedules

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): White Alcon IOL
- 2 (Type: ACTIVE_COMPARATOR): Yellow Alcon IOL
- 3 (Type: ACTIVE_COMPARATOR): White Hoya IOL
- 4 (Type: ACTIVE_COMPARATOR): Yellow Hoya IOL

Based on this trial design, predict the completion outcome and termination type (if applicable).